reference/13547282

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13547282

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1018
issn	0163-5581 1532-7914
issueIdentifier	6
pageRange	1007-1018
publicationName	Nutrition and Cancer
startingPage	1007
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_dead4cd962df430aa2ccf71b9ccfdfb6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9454a46f4411ea9e0eb3631975582778
bibliographicCitation	Li Y, Guo Y, Feng Z, Bergan R, Li B, Qin Y, Zhao L, Zhang Z, Shi M. Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells. Nutrition and Cancer. 2019 Apr 29;71(6):1007–18. doi: 10.1080/01635581.2019.1578387.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_307fac99141ad2d65d8b3d2b5bba0dc0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5cc15d20e5c946e84872e2c1036d0e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ea47f0052b5b96a80b153f28f145c03 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d8e4d74f6c878485c8492153f5318b6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19178c2b89a7d99b1ead737f3982aea0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94b076e64bd35c8cb2fab4f7e6c6066d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efc630d318c7bea1cc713fe04a28acc3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9440-3892 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_280928684bb447eb2b82cf299531032d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95524cd1bfd6503c91110e8afa08c47f
date	2019-04-29^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1080/01635581.2019.1578387 https://pubmed.ncbi.nlm.nih.gov/31032633
isPartOf	https://portal.issn.org/resource/ISSN/1532-7914 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6142 https://portal.issn.org/resource/ISSN/0163-5581
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells
discusses	http://id.nlm.nih.gov/mesh/M0465491 http://id.nlm.nih.gov/mesh/M0150739 http://id.nlm.nih.gov/mesh/M0479977 http://id.nlm.nih.gov/mesh/M0001491 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0543055 http://id.nlm.nih.gov/mesh/M0165532 http://id.nlm.nih.gov/mesh/M0283972 http://id.nlm.nih.gov/mesh/M0001348 http://id.nlm.nih.gov/mesh/M0237441
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D051267Q000378 http://id.nlm.nih.gov/mesh/D000077185Q000494 http://id.nlm.nih.gov/mesh/D058534Q000378 http://id.nlm.nih.gov/mesh/D015470Q000188 http://id.nlm.nih.gov/mesh/D051057Q000378 http://id.nlm.nih.gov/mesh/D004317Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000903Q000494 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D015470Q000473 http://id.nlm.nih.gov/mesh/D015398Q000187 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018922 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D015470Q000378 http://id.nlm.nih.gov/mesh/D000975Q000494 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D004357
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9734 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ae466b05dccb85064e6f20a462085b49 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe23b71532060659f522ccd4294354f9 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f56a221bc770a5fa884ac7d3634f29a8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8d8efb5335a904318b9014eccec9d3e9 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8

Showing number of triples: 1 to 69 of 69.